AVR 2.27% $9.00 anteris technologies ltd

I read last posts dat sez AHZ is $1 stock in 1-2 years I must...

  1. 63 Posts.
    lightbulb Created with Sketch. 1
    I read last posts dat sez AHZ is $1 stock in 1-2 years

    I must concur wit diz opinion, AF "Twiggy" is major shareholder, FMG shareholders are top 5 shareholders bar 1, new name and products coming online, large cash in bank, biotech stocks booming in US, many no income biotechs valued well over $1B. For AHZ to be at $1, the MC will be $1.2B as lots of shares issued already mainly to FMG shareholders who get dividends from FMG and buy other AF controlled stocks like AHZ, FMG or POS with them.

    As we have seen with ANL, FMG and POS, these stocks defy the universal physics principles of gravity and relativity but comply with quantum physics and poyson exponential distribution charts in statistics. The AHZ rocket ship to Mars has had a few false starts but with AF as captain and well fueled up and engine burning on der dock,

    Many beancounters say AHZ valued at 24c-55c and many LTH buy in at 5-10c when last mob sell cheap which leaves FMG people in total control but with large share register in top 20 open. As i surmize before, this is a cheap stock.

    Many ignore Pr Frasers laboratory work at their peril, his team are concocting more global formulas every week, expect AHZ to take 100% of Coridon (now Ademdus vaccines) and give Fraser options or royalties. With $30M in cash you will do something good with it. Expect cardiocell revolution and new products with factory starting to produce mass widgets. Expect large US company to get on share register just like happened with ANL, FMG etc - History repeats itself. AF will not let Pr Fraser be shafted this time by CSL or Merck.

    Its a takeover target pure and simple for the right price, If proactive investors and Baiileu Holst say its MV is 24-28c and 25-55c then they are the experts, the longer it trades this low the more likely it will be a takeover target for CSL and Merck, there is also a large gap in top 20 shareholders and lots of shares on issue 1.1B for such a small company. This exposes it to a large move onto the share register of 19.9%.

    I would not sell, i would accumulate slowly and quietly, volume is low and people are not selling much at all. Big mistake to sell now when its this cheap - AF will be richest man in Australia again, biotech is his long term interest.

    I expect a massive spike up when results come in or sales take off and watch for volume spikes on nothing days as that could be an accumulater - if i was Merck or CSL this would be a cheap easy buy at this level, if they wait next year it may be triple the cost.

    I do not sell, I wait for the next rally to 35c to skim then to $1
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$9.00
Change
0.200(2.27%)
Mkt cap ! $190.2M
Open High Low Value Volume
$8.90 $9.48 $8.88 $176.7K 19.75K

Buyers (Bids)

No. Vol. Price($)
2 590 $8.80
 

Sellers (Offers)

Price($) Vol. No.
$9.40 70 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.